| Open Document File Size: 256,50 KBShare Result on Facebook
Company G-CSF / Branded Pharmaceutical Products R&D Inc. / Amgen / Teva / / Country United States / / Event FDA Phase / / IndustryTerm filgrastim product / / MedicalCondition DF / chemotherapy-induced neutropenia / Cancer / gastrointestinal and pulmonary infections / Acute Respiratory Distress Syndrome / neutropenia / febrile neutropenia granulocyte colony-stimulating / fever / Pain / breast cancer receiving myeloablative chemotherapy / Febrile Neutropenia / Lung Cancer / Allergic Reactions / Non-Hodgkin Lymphoma / infection / Breast Cancer / Anemia / sepsis / Severe Neutropenia / / MedicalTreatment chemo / antibiotics / chemotherapy / / Organization European Medicines Agency / FDA / European Union / FDA Medical Imaging Drugs Advisory Committee / United States Food and Drug Administration / / Person EMA EU / MIU NA NME PBPC PD / / Product prednisolone / Neupogen / cyclophosphamide / XM02-01 / XM02-02INT / XM02 / CD34 / XM02-02 / / Technology pharmacokinetics / chemotherapy / pharmacodynamics / Medical Imaging / /
SocialTag |